Noggo E.v.
NOGGO E.V. is a Berlin-based nonprofit medical professional society serving approximately 950 gynecologic oncology physicians in Germany, operating clinical trials, the EXPRESSION patient survey series, continuing medical education, and the JAGO fellowship program, funded by membership fees and pharmaceutical industry sponsorships.
- Company typePrivate
- Founded1998
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Noggo E.v. does
NOGGO E.V. (Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie) is a Berlin-based registered nonprofit medical professional society founded in 1998 to improve recurrence-free survival and life expectancy of patients with gynecologic cancers. It is the largest membership organization in the field in Germany, with approximately 900–950 physician and medical professional members drawn from hospitals and private practices, and operates through 8 specialized working groups covering ovarian, breast, cervical and endometrial cancers, translational research, supportive therapies, global health, and benefit assessment of innovations, plus the JAGO (Young Academy Gynecologic Oncology) fellowship program founded in 2013.
The society's core offerings are clinical trial design and management (15+ active ENGOT-branded Phase I–IV trials), the EXPRESSION international patient survey series, accredited continuing medical education events including the annual "360° GYN-ONKOLOGIE" conference, webinars, masterclasses, and a members-only Mediathek of archived presentations, and the proprietary NOGGO GIS V1 HRD Assay validated in collaboration with the Institute for Hematopathology Hamburg and the ENGOT-PAOLA1 study group. NOGGO operates the Tumorbank Ovarian Cancer Network (TOC) at Charité Universitätsmedizin Berlin and integrates standard research tooling (RedCap, SurveyMonkey, doctorflix video platform). It coordinates with ENGOT, GCIG, AGO, DGHO, DGGG, and DAGG (patronage of JAGO).
Revenue is generated through tiered annual membership fees (€45–€75 per member, free for students) and "Fördermitgliedschaft" sponsor memberships from selected pharmaceutical companies including GSK, MSD, AstraZeneca, Roche, Daiichi Sankyo, Seagen, pharmaand, Clovis Oncology, PharmaMar, and Tesaro (historical). Sponsorship funds are concentrated in the JAGO fellowship program, where sponsors are explicitly barred from influencing educational content or fellow selection. The organization is governed by a board chaired by Prof. Dr. Dr. h.c. Jalid Sehouli and managed operationally by Managing Director Dr. Anna Oldenburg, supported by a lean ~12-person Berlin staff.
Noggo E.v. firmographics
Firmographics- Name
- Noggo E.v.
- Legal name
- Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e. V.
- Website
- https://noggo.de
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NOGGO E.V. is a Berlin-based nonprofit medical professional society serving approximately 950 gynecologic oncology physicians in Germany, operating clinical trials, the EXPRESSION patient survey series, continuing medical education, and the JAGO fellowship program, funded by membership fees and pharmaceutical industry sponsorships.
- Ownership category
- akta.pro rank
Noggo E.v. industry classification
Industry- Product category
- Medical Professional Society
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Gynecologic Oncology (HLAKAFAF)
- akta.pro secondary industries
- Gynecologic Oncology (HLAKAJAD), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)
Keywords
Where Noggo E.v. is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Noggo E.v. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: Annual membership fees are the primary revenue stream. Fees vary by professional category: attending physicians (Chefärztin/Chefarzt) pay €75/year; senior physicians (Oberärztin/Oberarzt) pay €60/year; resident/office-based physicians pay €45/year; students attend free of charge. Pharmaceutical companies support the society through 'Fördermitgliedschaft' (sponsor membership).
- Industry Sponsorship & Grants: Pharmaceutical companies (e.g., GSK, MSD, AstraZeneca, Roche, Daiichi Sankyo, Seagen, pharmaand, Clovis Oncology, PharmaMar, Tesaro) provide financial sponsorship for educational programs, particularly the JAGO (Young Academy Gynecologic Oncology) fellowship program. Sponsors do not influence educational content or selection processes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Attending Physicians (Chefärztin/Chefarzt): €75 per year |
| Subscription | Annual | Senior Physicians (Oberärztin/Oberarzt): €60 per year |
| Subscription | Annual | Office-Based Physicians (niedergelassene Ärztin/Arzt): €75 per year |
| Subscription | Annual | General Physicians (Ärztin/Arzt): €45 per year |
| Subscription | Annual | Other professionals: €45 per year |
| Subscription | Annual | Students: Free |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Noggo E.v. product offering
Product offeringCore offering
NOGGO E.V. is a nonprofit medical professional society that conducts multi-center clinical studies, runs longitudinal patient surveys (e.g., EXPRESSION series), and delivers continuing medical education, fellowships, and translational research programs in gynecologic oncology. It coordinates working groups across ovarian, breast, cervical/endometrial, supportive therapy, and health technology assessment topics, and operates the Tumorbank Ovarian Cancer Network biobank.
Product overview
NOGGO e.V. (Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie) is a professional medical society and research organization operating as a unified digital platform and program portfolio. The core offering combines a member-accessible website platform with integrated clinical research services, the EXPRESSION patient survey series, educational programming (including Masterclass, JAGO fellowship, webinars, and annual conferences), media library access, and scientific publication support. The organization functions as a network of approximately 950 members facilitating clinical trials and professional education in gynecological oncology across Germany.
Differentiator
Problem solved
Functional benefit
Brands
- JAGO: Junge Akademie gynäkologische Onkologie: A career development and training program for young physicians in gynecological oncology, offering a curriculum of five modules, workshops, project groups, and networking opportunities with senior leaders.
Products and services
- JAGO Fellowship Program Structured post-doctoral fellowship program for young physicians and trainees specializing in gynecologic oncology; combines clinical rotation, research training, and mentorship.
- Educational Events (Fortbildungsveranstaltungen) Continuing medical education events including conferences, symposia, workshops, and webinars focused on gynecologic oncology practice and research.
- Clinical Studies (Klinische Studien) Multi-center investigator-initiated clinical trials and translational research studies in gynecologic oncology, conducted in collaboration with academic sites and industry sponsors.
- EXPRESSION Patient Survey Series Longitudinal patient-reported outcomes survey program tracking quality of life, treatment experiences, and psychosocial outcomes of gynecologic cancer patients.
- Annual Society Membership Annual membership in NOGGO E.V. providing access to the Mediathek educational content library, working group participation, and member events; tiered pricing with reduced rates for students and trainees.
Quantifiable outcome
- NOGGO members receive a 30% discount on ESGO membership fees
- +4 more outcomes
Companies that use Noggo E.v.
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Noggo E.v. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature1 record
Noggo E.v. partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- ENGOT (European Network of Gynaecological Oncological Trial Groups)coreNOGGO is an active member of ENGOT and conducts multiple ENGOT-branded clinical trials (ENGOT-ov93/TREVI, ENGOT-ov89, ENGOT-en34, ENGOT-en24, ENGOT-en25, ENGOT-en29, ENGOT-ov83, ENGOT-ov51, ENGOT-ov65, ENGOT-Cx19, ENGOT-en10/DUO-E, ENGOT-en12, ENGOT-en15, ENGOT-en31, ENGOT-ov47-TR). NOGGO also coordinates European patient surveys within the ENGOT framework.
- GCIG (Gynecological Cancer InterGroup)coreNOGGO collaborates with GCIG on international patient surveys (Expression VI, Expression IX) and clinical trial consensus statements, contributing to global harmonization of gynecologic cancer research.
- AGO (Arbeitsgemeinschaft Gynäkologische Onkologie) / AGO StudiengruppecoreNOGGO collaborates with AGO-Studiengruppe on clinical trials (e.g., AG Ovarialkarzinom working with the OVAR commission, AGO-Studiengruppe, and the European Competence Center for Ovarian Cancer / EKZE at Charité). NOGGO and AGO have cooperated for over 20 years.
- DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie)minorNOGGO works with DGHO in drafting statements for the Gemeinsamer Bundesausschuss (G-BA) within the benefit assessment procedure for gynecologic oncology innovations.
- DGGG (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe)minorNOGGO collaborates with DGGG in drafting statements for the G-BA benefit assessment procedure.
- Charité Universitätsmedizin BerlincoreCharité is the primary academic partner of NOGGO. Several NOGGO leaders (Prof. Dr. Klaus Pietzner, Prof. Dr. Dr. h.c. Jalid Sehouli) hold positions at Charité. NOGGO operates the European biobank (TOC/Tumorbank Ovarian Cancer Network) at Charité and conducts multiple collaborative clinical trials.
- DAGG (Deutsche Akademie für Gynäkologische Onkologie) - PatronageminorDAGG provides the patronage (Schirmherrschaft) for the JAGO (Young Academy Gynecologic Oncology) program.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Noggo E.v. competitors and assessment
Company assessmentRegional players
- Society of Gynecologic Oncology (SGO): SGO is the leading US-based gynecologic oncology professional society. It is comparable as a specialty medical society with similar mission (research, education, advocacy) but operates primarily in North America rather than DACH.
Emerging players
- Stiftung Eierstockkrebs: A German patient advocacy foundation focused on ovarian cancer that NOGGO collaborates with for patient outreach. It is comparable as a stakeholder organization in the German gynecologic oncology ecosystem.
Broad incumbents
- European Society for Medical Oncology (ESMO): ESMO is a broader European oncology professional society whose audience overlaps with NOGGO members. It is comparable as a larger incumbent serving medical oncology professionals across all cancer types.
- International Gynecologic Cancer Society (IGCS): IGCS is the leading international society for gynecologic cancer research and education. It is comparable as a higher-level international professional body serving the same specialty community.
- European Society of Gynaecological Oncology (ESGO): ESGO is the broader European society for gynecologic oncology. NOGGO members receive a 30% discount on ESGO membership, indicating direct overlap in audience and educational programming across Europe.
Others
- Gynecological Cancer InterGroup (GCIG): GCIG is an international consortium of trial groups coordinating gynecologic cancer research. NOGGO is an active GCIG collaborator, making GCIG directly comparable as a coordinating network for the same clinical research agenda.
- European Network of Gynaecological Oncological Trial Groups (ENGOT): ENGOT is the European cooperative network for gynecologic cancer trial groups. NOGGO is a member and runs multiple ENGOT-branded trials, making ENGOT a directly comparable trial coordination platform.
Direct peers
- Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG): DGGG is the umbrella German OB/GYN professional society. NOGGO collaborates with DGGG on G-BA statements; it is comparable as a peer physician society addressing overlapping gynecologic topics.
- Arbeitsgemeinschaft Gynäkologische Onkologie (AGO): AGO is the other major German gynecologic oncology professional society with whom NOGGO cooperates on trials (AGO-Studiengruppe, EKZE). It is directly comparable as a parallel physician society focused on gynecologic cancers in the same geography.
- Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO): DGHO is the German professional society for hematology and medical oncology, with whom NOGGO collaborates on G-BA benefit assessment statements. It is directly comparable as a German physician society focused on oncology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Noggo E.v. social profiles
Digital presenceNoggo E.v. compliance and trust
Trust signalCompliance1 record
Noggo E.v. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Noggo E.v. leadership team
Management profileNumber of profiles
Profiles10 records
Noggo E.v. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Noggo E.v. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Noggo E.v.
What does Noggo E.v. do?
NOGGO E.V. is a nonprofit medical professional society that conducts multi-center clinical studies, runs longitudinal patient surveys (e.g., EXPRESSION series), and delivers continuing medical education, fellowships, and translational research programs in gynecologic oncology. It coordinates working groups across ovarian, breast, cervical/endometrial, supportive therapy, and health technology assessment topics, and operates the Tumorbank Ovarian Cancer Network biobank.
Is Noggo E.v. a public or private company?
Noggo E.v. is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Noggo E.v. founded?
Noggo E.v. was founded in 1998. It employs 11 to 50 people.
Where is Noggo E.v. based?
Noggo E.v. is headquartered in Berlin, Germany, in the Europe region.
How does Noggo E.v. make money?
Two revenue lines are on record. Membership Fees are the primary driver. The others are industry Sponsorship & Grants.
Who are Noggo E.v.'s main competitors?
Society of Gynecologic Oncology (SGO) is listed as a regional player. Stiftung Eierstockkrebs is listed as an emerging player. Broad incumbents are European Society for Medical Oncology (ESMO), International Gynecologic Cancer Society (IGCS) and European Society of Gynaecological Oncology (ESGO). Others are Gynecological Cancer InterGroup (GCIG) and European Network of Gynaecological Oncological Trial Groups (ENGOT). Direct peers are Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO).
Does Noggo E.v. have an API?
No public API is recorded for Noggo E.v..
What industry is Noggo E.v. in?
Noggo E.v.'s product category is Medical Professional Society. Its primary akta.pro industry code is HLAKAFAF, Gynecologic Oncology, with a secondary code of HLAKAJAD, Gynecologic Oncology. Its NAICS code is 5417 and its SIC code is 8011.